首页 正文

Living donor liver transplantation for neo-adjuvant treated, unresectable intrahepatic cholangiocarcinoma (LIVINCA): study protocol for a one-armed, mono-centric, non-randomized trial

{{output}}
Background Intrahepatic cholangiocarcinoma has demonstrated a consistently increasing incidence in recent years. In cases of unresectability, palliative chemotherapy often remains the only option, typically associated with a poor prognosis. Liver transplantati... ...